Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is an aggressive and lethal cancer with a low 5 year survival rate. Identification of new therapeutic targets and its inhibitors remain essential for ESCC prevention and treatment. METHODS: TYK2 protein levels were checked by immunohistochemistry...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Exp Clin Cancer Res
Egile Nagusiak: Jia, Xuechao, Huang, Chuntian, Hu, Yamei, Wu, Qiong, Liu, Fangfang, Nie, Wenna, Chen, Hanyong, Li, Xiang, Dong, Zigang, Liu, Kangdong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7972218/
https://ncbi.nlm.nih.gov/pubmed/33731185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-01903-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak